European Commission Orders Illumina to Unwind Grail Merger
- October 13, 2023
The European Commission formally ordered October 12 genetic sequencing firm Illumina Inc. to divest cancer detection company Grail and “restore the situation prevailing before the completion of the acquisition.”
ARTICLE TAGS
You must be logged in to access this content.